1. Pelosof LC, Gerber DE. Paraneoplastic Syndromes:An Approach to
Diagnosis and Treatment. Mayo Clin Proc. 2010;85(9):838-854. 2. DeVita, Hellman, Rosenberg. Cancer principles & practice of oncology. 8 th ed. Philadelphia, Wolters Kluwer: 2008. 3. Sugiyono S, Abdulmuthaib. Sindrom Paraneoplastik dalam: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S (penyunting). Buku Ajar Ilmu Penyakit Dalam Edisi ke-V. Jakarta. Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia. 2009. 4. Spinazze S, Schrijvers D. Metabolic emergencies. 2006;58:79-89. 5. Raftopoulos H. Diagnosis and management of hyponatremia in cancer patients. Support Care Cancer. 2007;15:1341-1347. 6. Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064-2072. 7. Lumachi F, Brunello A, Roma A, Basso U. Medical treatment of malignancy-associated hypercalcemia. Am Heart J. 2008;15:415-421. 8. Stewart AF. Hypercalcemia associated with cancer. Curr Med Chem. 2005;352:373-379. 9. Nimalasena S, Freeman A, Harland S. Paraneoplastic Cushings syndrome in prostate cancer: a difficult management problem. BJU int. 2008;101:424-427. 10. Nieman LK. Medical therapy of Cushings disease. Pituitary. 2002;5:7782. 11. Nayar MK, Lombard MG, Furlong NJ, McNulty SJ, Hardy KJ, Vora J. Diagnosis and management of nonislet cell tumor hypoglycemia: case series and review of the literature. Endocrinologist. 2006;16(4):227-230.